Treatment of Keratoconus Using Collagen Cross-Linking
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of collagen cross-linking in the
cornea in halting the progression and possibly partially reversing the effects of
keratoconus. Keratoconus is a progressive weakening in the cornea that causes irregular
astigmatism and thinning of the cornea. The overall effect is reduction of vision, and in
more advanced cases, scarring of the cornea that may lead to the need for corneal
transplantation. Cross-linking has been shown increase the rigidity of the cornea. The
patients would be treated once and then followed over 24 months. .